Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Asthma
- Cardiology
  - BACK
  - Cardiology
  - Hypercholesterolemia
  - Lp(a)
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - Adult Vaccinations
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - C3 Glomerulopathy
  - IgAN
  - IgAN & C3G
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - Chronic Obstructive Pulmonary Disease
  - Interstitial Lung Disease
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

alex.hogeland@engagehealthmedia.com

Personalized Treatment Selection for Patients With Relapsing Multiple Sclerosis

Personalized Treatment Selection for Patients With Relapsing Multiple Sclerosis

expert roundtables
By Robert A. Bermel, MD, MBA; Fred D. Lublin, MD; Robert T. Naismith, MD

The Individualized Selection and Sequencing of JAK Inhibitors for Myelofibrosis

The Individualized Selection and Sequencing of JAK Inhibitors for Myelofibrosis

clinical topic updates
By Andrew Kuykendall, MD

Myelofibrosis: Clinical Challenges and Patient-Provider Discussions

Myelofibrosis: Clinical Challenges and Patient-Provider Discussions

patient care perspectives
By Gabriela S. Hobbs, MD

Transfusion Independence, Quality of Life, and Survival Outcomes in Myelofibrosis

Transfusion Independence, Quality of Life, and Survival Outcomes in Myelofibrosis

patient care perspectives
By Lucia Masarova, MD

Emerging Investigational Agents and Combination Therapies for Myelofibrosis

Emerging Investigational Agents and Combination Therapies for Myelofibrosis

clinical topic updates
By Andrew Kuykendall, MD

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?